Answers are grounded in this paper and cite their sources.
Luminex X - Map technology has revolutionized anti-HLA antibody detection globally enabling detection of low level antibodies, which were not detected previously by the conventional Complement Dependent Cytotoxicity crossmatch (CDCXM). Luminex - X - Map technology is being used globally for anti -HLA antibody detection using four kinds of kits: pooled, phenotype, single antigen bead assay and luminex crossmatch (LXM) using 5.6 microns size polystyrene beads. LXM has gained wide acceptance in the Indian subcontinent because of its ability to detect low levels of sensitization, ease of use, ability to characterize as HLA - class I or II reactivity and its price.
No takes yet. Share an insight, caveat, or question.
Narain et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: